International Urogynecology Journal

, Volume 27, Issue 3, pp 367–375 | Cite as

Polyacrylamide hydrogel (Bulkamid®) for stress urinary incontinence in women: a systematic review of the literature

  • Anushuya Devi KasiEmail author
  • Vasilios Pergialiotis
  • Despina N. Perrea
  • Azar Khunda
  • Stergios K. Doumouchtsis
Review Article


Introduction and hypothesis

Polyacrylamide hydrogel (PAHG, Bulkamid®) is one of several injectable agents currently used for the treatment of women with urinary stress incontinence. Although bulking agents appear to have lower efficacy rates compared to other surgical treatments, current evidence based on large prospective or comparative studies as well as systematic reviews is limited. The purpose of this study was to conduct a systematic review on the efficacy of PAHG in the treatment of female patients with stress urinary incontinence with regard to reproducibility, feasibility, safety and clinical outcome.


We searched MEDLINE (1966–2015), Scopus (2004–2015), POPLINE (1974–2015) and (2008–2015) along with reference lists of electronically retrieved studies. Observational studies, prospective, retrospective and randomized controlled studies were included. Two reviewers independently selected studies, assessed the risk of bias and tabulated data to structured forms.


We included 8 studies, which enrolled a total of 767 patients who received treatment with PAHG. We found that 186 of 767 women (24.3 %, range 12–35 %) required reinjection in order to achieve adequate efficacy. The most frequent adverse effects were pain at the site of injection (4–14 %) and urinary tract infections (3–7 %). Both the number of incontinence episodes/24 h and the number of ml/24 h were significantly reduced 1 year following treatment and the quality of life of patients was significantly improved.


PAHG is a safe intervention for treating women with stress urinary incontinence, but repeat injections are often required. Further research is mandated in the field in order to compare its efficacy to other bulking agents.


Bulkamid Polyacrylamide hydrogel Stress urinary incontinence 


Conflicts of interest



  1. 1.
    National Institute for Health and Care Excellence (2013) NICE guidelines [CG171]. Urinary incontinence: the management of urinary incontinence in women.
  2. 2.
    Kirchin V, Page T, Keegan PE, Atiemo K, Cody JD, McClinton S (2012) Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev 2:CD003881. doi: 10.1002/14651858.CD003881.pub3 PubMedGoogle Scholar
  3. 3.
    Bianchi-Ferraro AM, Jarmy-DiBella ZI, de Aquino Castro R, Bortolini MA, Sartori MG, Girão MJ (2014) Randomized controlled trial comparing TVT-O and TVT-S for the treatment of stress urinary incontinence: 2-year results. Int Urogynecol J 25(10):1343–1348CrossRefPubMedGoogle Scholar
  4. 4.
    Committee Opinion No. 603: Evaluation of uncomplicated stress urinary incontinence in women before surgical treatment (2014). Obstet Gynecol 123(6):1403–1407Google Scholar
  5. 5.
    Ter Meulen PH, Berghmans LC, van Kerrebroeck PE (2003) Systematic review: efficacy of silicone microimplants (Macroplastique) therapy for stress urinary incontinence in adult women. Eur Urol 44(5):573–582Google Scholar
  6. 6.
    Klarskov N, Lose G (2008) Urethral injection therapy: what is the mechanism of action? Neurourol Urodyn 27(8):789–792CrossRefPubMedGoogle Scholar
  7. 7.
    Fatton B, Savary D, Velemir L (2009) Obstructive suburethral mass following injection of dextranomer/hyaluronic acid copolymer. Int J Gynaecol Obstet 104(1):73–74CrossRefPubMedGoogle Scholar
  8. 8.
    Loisel C, Secco M, Rocher-Barrat A, Caremel R, Grise P (2008) Periurethral pseudocysts following urethral injections of Zuidex: review of the literature. Prog Urol 18(13):1038–1043CrossRefPubMedGoogle Scholar
  9. 9.
    Madjar S, Sharma AK, Waltzer WC, Frischer Z, Secrest CL (2006) Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J Urol 175(4):1408–1410CrossRefPubMedGoogle Scholar
  10. 10.
    Kotb AF, Campeau L, Corcos J (2009) Urethral bulking agents: techniques and outcomes. Curr Urol Rep 10(5):396–400CrossRefPubMedGoogle Scholar
  11. 11.
    Lose G, Mouritsen L, Nielsen JB (2006) A new bulking agent (polyacrylamide hydrogel) for treating stress urinary incontinence in women. BJU Int 98(1):100–104CrossRefPubMedGoogle Scholar
  12. 12.
    Zarini E, Supino R, Pratesi G, Laccabue D, Tortoreto M, Scanziani E, Ghisleni G, Paltrinieri S, Tunesi G, Nava M (2004) Biocompatibility and tissue interactions of a new filler material for medical use. Plast Reconstr Surg 114(4):934–942CrossRefPubMedGoogle Scholar
  13. 13.
    Bello G, Jackson IT, Keskin M, Kelly C, Dajani K, Studinger R, Kim EM, Lincoln D, Silberberg B, Lee A (2007) The use of polyacrylamide gel in soft-tissue augmentation: an experimental assessment. Plast Reconstr Surg 119(4):1326–1336CrossRefPubMedGoogle Scholar
  14. 14.
    Christensen LH, Breiting VB, Aasted A, Jørgensen A, Kebuladze I (2003) Long-term effects of polyacrylamide hydrogel on human breast tissue. Plast Reconstr Surg 111(6):1883–1890CrossRefPubMedGoogle Scholar
  15. 15.
    Christensen LH, Nielsen JB, Mouritsen L, Sørensen M, Lose G (2008) Tissue integration of polyacrylamide hydrogel: an experimental study of periurethral, perivesical, and mammary gland tissue in the pig. Dermatol Surg 34(Suppl 1):S68–S77, discussion S77PubMedGoogle Scholar
  16. 16.
    Lose G, Sørensen HC, Axelsen SM, Falconer C, Lobodasch K, Safwat T (2010) An open multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and mixed urinary incontinence. Int Urogynecol J 21(12):1471–1477PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Toozs-Hobson P, Al-Singary W, Fynes M, Tegerstedt G, Lose G (2012) Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and stress-predominant mixed incontinence. Int Urogynecol J 23(10):1373–1378PubMedCentralCrossRefPubMedGoogle Scholar
  19. 19.
    Leone Roberti Maggiore U, Alessandri F, Medica M, Gabelli M, Venturini PL, Ferrero S (2013) Outpatient periurethral injections of polyacrylamide hydrogel for the treatment of female stress urinary incontinence: effectiveness and safety. Arch Gynecol Obstet 288(1):131–137CrossRefPubMedGoogle Scholar
  20. 20.
    Martan A, Masata J, Svabik K, Krhut J (2014) Transurethral injection of polyacrylamide hydrogel (Bulkamid®) for the treatment of female stress or mixed urinary incontinence. Eur J Obstet Gynecol Reprod Biol 178:199–202CrossRefPubMedGoogle Scholar
  21. 21.
    Trutnovsky G, Tamussino K, Greimel E, Bjelic-Radisic V (2011) Quality of life after periurethral injection with polyacrylamide hydrogel for stress urinary incontinence. Int Urogynecol J 22(3):353–356CrossRefPubMedGoogle Scholar
  22. 22.
    Beraru A, Droupy S, Wagner L, Soustelle L, Muyschondt C, Ben Naoum K, Grés P, Boukaram M, Costa P (2014) Efficacy of periurethral injections of polyacrylamide hydrogel (Bulkamid®) and quality of life of patients with urinary incontinence due to sphincter deficiency (IUE-IS). Prog Urol 24(8):501–510CrossRefPubMedGoogle Scholar
  23. 23.
    Sokol ER, Karram MM, Dmochowski R (2014) Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter North American study. J Urol 192(3):843–849CrossRefPubMedGoogle Scholar
  24. 24.
    Vecchioli-Scaldazza CV, Smaali C, Morosetti C, Azizi B, Giannubilo W, Ferrara V (2014) Polyacrylamide hydrogel (Bulkamid®) in female patients of 80 or more years with urinary incontinence. Int Braz J Urol 40(1):37–43PubMedGoogle Scholar
  25. 25.
    Davis NF, Kheradmand F, Creagh T (2013) Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents. Int Urogynecol J 24(6):913–919CrossRefPubMedGoogle Scholar
  26. 26.
    Martan A, Masata J, Svabik K, El-Haddad R, Hubka P (2011) Transurethral injection of polyacrylamide hydrogel (Bulkamid®) for the treatment of female stress urinary incontinence and changes in the cure rate over time. Ceska Gynekol 76(6):476–481PubMedGoogle Scholar
  27. 27.
    Cloutier J, Blais AS, Moore K, Bolduc S (2013) Prospective study using a new bulking agent for the treatment of vesicoureteral reflux: polyacrylamide hydrogel. J Urol 190(3):1034–1037CrossRefPubMedGoogle Scholar
  28. 28.
    Mohr S, Siegenthaler M, Mueller MD, Kuhn A (2013) Bulking agents: an analysis of 500 cases and review of the literature. Int Urogynecol J 24(2):241–247CrossRefPubMedGoogle Scholar
  29. 29.
    Leone Roberti Maggiore U, Alessandri F, Medica M, Gabelli M, Venturini PL, Ferrero S (2012) Periurethral injection of polyacrylamide hydrogel for the treatment of stress urinary incontinence: the impact on female sexual function. J Sex Med 9(12):3255–3263CrossRefPubMedGoogle Scholar
  30. 30.
    Gopinath D, Smith ARB, Reid FM (2012) Periurethral abscess following polyacrylamide hydrogel (Bulkamid®) for stress urinary incontinence. Int Urogynecol J 23:1645–1648CrossRefPubMedGoogle Scholar

Copyright information

© The International Urogynecological Association 2015

Authors and Affiliations

  • Anushuya Devi Kasi
    • 1
    Email author
  • Vasilios Pergialiotis
    • 2
  • Despina N. Perrea
    • 2
  • Azar Khunda
    • 1
  • Stergios K. Doumouchtsis
    • 1
    • 2
  1. 1.Department of Obstetrics and Gynaecology, Urogynaecology UnitSt. George’s University Hospitals NHS Foundation TrustLondonUK
  2. 2.Laboratory of Experimental Surgery and Surgical Research N.S. ChristeasMedical School, University of AthensAthensGreece

Personalised recommendations